RYTALVO Trademark

Trademark Overview


On Wednesday, July 1, 2020, a trademark application was filed for RYTALVO with the United States Patent and Trademark Office. The USPTO has given the RYTALVO trademark a serial number of 90030950. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 13, 2023. This trademark is owned by AbbVie Stemcentrx LLC. The RYTALVO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
rytalvo

General Information


Serial Number90030950
Word MarkRYTALVO
Filing DateWednesday, July 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2020

Trademark Statements


Goods and Servicespharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbVie Stemcentrx LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorth Chicago, IL 60064

Party NameAbbVie Stemcentrx LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorth Chicago, IL 60064

Trademark Events


Event DateEvent Description
Monday, February 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 30, 2022SOU EXTENSION 3 GRANTED
Thursday, June 30, 2022SOU EXTENSION 3 FILED
Thursday, June 30, 2022TEAS EXTENSION RECEIVED
Friday, December 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 22, 2021SOU EXTENSION 2 GRANTED
Wednesday, December 22, 2021SOU EXTENSION 2 FILED
Wednesday, December 22, 2021TEAS EXTENSION RECEIVED
Saturday, July 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 8, 2021SOU EXTENSION 1 GRANTED
Thursday, July 8, 2021SOU EXTENSION 1 FILED
Thursday, July 8, 2021TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 7, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 6, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, October 6, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 6, 2020ASSIGNED TO EXAMINER
Thursday, July 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 4, 2020NEW APPLICATION ENTERED